Hennion & Walsh Asset Management, Inc.
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1861642
Parsippany, NJ
Position in ACAD
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$2,613,237
+$371,010 QoQ
Shares Held
103,290
+2.5% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1
of 24 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $200,308,891 across 60 Biotechnology names. ACAD ranks #31 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
48,019 | $11,571,138 | |
| 2 | CELC |
Celcuity Inc.
|
100,368 | $10,500,500 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
276,696 | $10,182,412 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
171,470 | $9,741,210 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
342,883 | $7,495,422 | |
| 6 | QURE |
uniQure N.V.
|
142,113 | $6,545,724 | |
| 7 | KURA |
Kura Oncology, Inc.
|
568,845 | $6,240,229 | |
| 8 | ARDX |
Ardelyx, Inc.
|
1,211,690 | $6,179,619 |
All Filings in ACAD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,613,237 | 103,290 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $2,242,227 | 100,729 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,773,726 | 103,846 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,811,139 | 131,731 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,022,409 | 140,121 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,176,923 | 131,061 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $1,896,013 | 103,325 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,473,926 | 95,834 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,665,251 | 102,477 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,644,033 | 142,998 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $3,604,626 | 115,127 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,918,412 | 140,039 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $3,619,012 | 151,107 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,985,643 | 211,777 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $3,323,284 | 208,749 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $3,272,523 | 200,032 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,788,622 | 197,915 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $5,122,336 | 211,492 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $4,438,217 | 190,155 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,014,100 | 181,463 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,099,934 | 168,099 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,105,399 | 159,124 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||